BIOMICROFLUIDICS 5, 013409 共2011兲 A microfluidic membrane device to mimic critical components of the vascular microenvironment Suthan Srigunapalan,1,2 Cameron Lam,1 Aaron R. Wheeler,2,3 and Craig A. Simmons1,2,a兲

First Page		Document Content
Date: 2011-08-09 14:23:19 Cytokines Immune system Selectins Cell biology Hematology Leukocyte extravasation E-selectin Tumor necrosis factor alpha CCL2 Monocyte VCAM-1 Tumor necrosis factor superfamily		BIOMICROFLUIDICS 5, 013409 共2011兲 A microfluidic membrane device to mimic critical components of the vascular microenvironment Suthan Srigunapalan,1,2 Cameron Lam,1 Aaron R. Wheeler,2,3 and Craig A. Simmons1,2,a兲 Add to Reading List Source URL: microfluidics.utoronto.ca Download Document from Source Website File Size: 1,45 MB Share Document on Facebook

	#4503 A Small Molecule Glycomimetic Antagonist of E-selectin (GMIPrevents Pancreatic Tumor Metastasis and Offers Improved Efficacy of Chemotherapy Maria M. Steele1, BS, Prakash Radhakrishnan1, PhD, John L. Magnani DocID: 1vkKU - View Document
	E-selectin Antagonist GMI-1271 Shows a Favorable Safety, PK and Bleeding Profile in Phase I Studies of Healthy Volunteers of Medicine/Division of Hematology Oncology, University of Michigan, Ann Arbor, MI;2Section of Vas DocID: 1v16h - View Document
	GMI-1271, a Novel E-Selectin Antagonist, Combined with Induction Chemotherapy in Elderly Patients with Untreated AML Daniel J. DeAngelo*1, Brian A. Jonas2, Dale L. Bixby3, Pamela S. Becker4, Michael E. O’Dwyer5, Anjali DocID: 1uWZ3 - View Document
	ADMINISTRATION OF THE DUAL E-SELECTIN/CXCR4 ANTAGONIST, GMI-1359, RESULTS IN A UNIQUE PROFILE OF TUMOR MOBILIZATION FROM THE BONE MARROW AND FACILITATION OF CHEMOTHERAPY IN A MURINE MODEL OF FLT3 ITD AML Abstract # 2826 DocID: 1uSr7 - View Document
	The Dual E-selectin/CXCR4 Antagonist GMI-1359 Exerts Anti-leukemia Efficacy Against FLT3-ITDmutated Acute Myeloid Leukemia in A Patient-derived Xenograft Murine Model Mouse-1 Mouse-2 DocID: 1uSbg - View Document